Primary Citation PubMed: 23163887
Citations in PubMed
This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.
Data mentions are occurrences of PDB IDs in the full text articles from the
PubMedCentral Open Access Subset
of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed.
Article titles can be filtered by keywords and sorted by year.
PubMed ID is not available.
Published in 2015
Table 1 Antiviral Activity and Solubility Data for Compounds 1 - 3 and FDA-Approved NNRTIs compd WT EC 50 (nM) Y181C EC 50 (nM) K103N/Y181C EC 50 (nM) solubility (μg/mL) 1 0.055 49 220 NA 2 0.... 1 46 24 510 3 0.32 16 85 10.8 rilpivirine 0.67 0.65 2 0.02–0.24 nevirapine 110 NA NA 167 efavirenz 2 10 30 68 General Structure Details for RT (WT), RT (Y181C), and RT (K103N/Y181C) To elucidate the effects of K103N and Y181C mutations on inhibitor binding, we determined crystal structures of RT (Y181C) and RT (K103N/Y181C) in complex with compound 1 to compare with the previously determined RT (WT): 1 crystal structure (PDB code: 4H4M).
Publication Year: 2015
The RCSB PDB (citation) is managed by two members of the Research Collaboratory for Structural Bioinformatics: Rutgers and UCSD/SDSC
RCSB PDB is a member of the
The RCSB PDB is funded by a grant (DBI-1338415) from the
National Science Foundation, the
National Institutes of Health, and the
US Department of Energy.